Is Amlodipine Actually Bad for Your Kidneys?

For most people, amlodipine is not bad for the kidneys, and getting high blood pressure under control is one of the best things you can do to protect them. High pressure slowly scars the kidneys’ tiny filters, and any drug that brings pressure down eases that strain. The pill isn’t a complete kidney-protection drug on its own, though, which is why doctors treat it differently once kidney disease or protein in the urine is involved. The worry you may have read online usually comes from comparisons with other drugs, not from amlodipine damaging healthy kidneys.

What the Big Long-Term Trials Found

Kidney function is usually tracked with eGFR, a score on your blood test report that estimates how well your kidneys filter. A score under 60 means reduced function. In a huge US blood pressure trial, people on amlodipine reached kidney failure no more often than those on the diuretic chlorthalidone, including people who already had reduced kidney function.1PubMed. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) After 4 years, the kidney filtering score was actually 3 to 6 points higher on amlodipine than on the diuretic.2PubMed. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Following people for 9 years, amlodipine matched the diuretic for kidney failure, heart attacks, strokes and death in people with a filtering score under 60.3PubMed Central. Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR “No worse than a diuretic” is reassuring because diuretics are a long-trusted first-choice blood pressure drug.

Kidney failure here was a serious, lasting outcome, such as needing dialysis or a transplant, or a large sustained fall in filtering. The drug wasn’t being judged on one odd lab result. A single score can wobble from day to day with hydration, illness and lab variation, so the trend over several tests matters more than one reading.

A trial of high-risk people taking two-drug combination pills found kidney disease worsened in 2.0% on benazepril plus amlodipine versus 3.7% on benazepril plus a diuretic.4PubMed. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial Paired with an ACE inhibitor, then, amlodipine cut the chance of kidney decline roughly in half compared with the diuretic pairing. Guidelines often favor that pairing as a starting combination for high-risk people.5PubMed. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

Where the Concern Comes From in Kidney Disease

The concern traces mostly to one trial of African Americans with kidney damage from high blood pressure. The ACE inhibitor ramipril protected their kidneys better than amlodipine used alone.6PubMed Central. The African American Study of Kidney Disease and Hypertension (AASK): New Findings After the first months, filtering fell about 3.2 points a year on amlodipine versus about 2.1 on ramipril, a 36% slower decline with ramipril.7JAMA. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial In the first 3 months, though, filtering rose about 4 points more on amlodipine, so total change over the whole trial didn’t differ significantly.8JAMA. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial Compared with the beta-blocker metoprolol, amlodipine showed no difference in kidney outcomes in the same trial.9PubMed. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial That early rise shouldn’t be read as healing: a higher number soon after starting can reflect harder-working filters, and the bump faded.

A slower decline on ramipril means ramipril was better at protecting. It doesn’t mean amlodipine produced a decline that wouldn’t have happened anyway, since this kind of kidney disease tends to progress regardless. So the researchers advised caution using amlodipine as the only drug in mild to moderate kidney disease.10PubMed Central. The African American Study of Kidney Disease and Hypertension (AASK): New Findings The usual fix is adding an ACE inhibitor or ARB, not stopping the drug.

This trial speaks to a specific group, not everyone on amlodipine. Most people with healthy or mildly reduced kidneys aren’t in that situation.

Why might this happen? Amlodipine relaxes the small blood vessel feeding each kidney filter more than the one draining it, which can raise pressure inside the filter.11PubMed Central. Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension Other studies found it widens both vessels and boosts flow through the filters.12Current Therapeutic Research – Clinical and Experimental. Effects of amlodipine, a calcium channel blocker, on rat renal arterioles The effect inside the kidney looks mixed, which fits with amlodipine protecting less than ACE inhibitors yet not being harmful in big trials. Adding an ACE inhibitor or ARB relaxes the draining vessel, offsetting the imbalance described for amlodipine alone.

Amlodipine and Protein in Your Urine

Protein in the urine, which your report may list as albuminuria and which is measured by a urine protein test (UACR), is an early sign of kidney strain. The test compares albumin with creatinine in a urine sample, which corrects for how dilute the urine is, so no collection over a whole day is needed. A single high result isn’t a diagnosis, because exercise, fever, infection or a very concentrated sample can raise it temporarily, so doctors usually repeat it. Higher results mean more leakage, and a result that falls after treatment is a good sign.

On its own, amlodipine doesn’t do much here. In people with type 2 diabetes and kidney disease, it lowered blood pressure but left protein in the urine unchanged.13PubMed. Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy In people with ordinary high blood pressure, lisinopril lowered urine protein while amlodipine did not.14PubMed. Effects of lisinopril and amlodipine on microalbuminuria and renal function in patients with hypertension A separate study found no meaningful drop after 8 weeks of amlodipine.15Indian Journal of Nephrology. Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study In one study of people with kidney disease, protein rose on amlodipine over 12 months.16PubMed. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases That is a single result among several that mostly found no change, so it suggests a lack of benefit rather than a dependable harm.

Lowering pressure isn’t always enough because protein leakage depends on pressure inside the filters, not just arm readings. ACE inhibitors (names ending in -pril) and ARBs (ending in -sartan) ease that inner pressure directly, which is why two people with the same reading can respond differently.

Combinations work. Pills pairing amlodipine with an ACE inhibitor reduced protein in people with diabetic kidney disease,17PubMed Central. Effects of Calcium Channel Blockers on Proteinuria in Patients With Diabetic Nephropathy and amlodipine plus fosinopril lowered it more than either drug alone.18PubMed. Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients If you have protein in your urine, amlodipine is usually best as a partner drug. If your urine protein test is normal, amlodipine’s lack of effect on protein is mostly irrelevant, since there is no leak to reduce.

Ask whether you’ve had a urine protein test recently. People with diabetes should usually have one yearly. If protein is present, ask whether you’re on an ACE inhibitor or ARB too.

Other Calcium Channel Blockers That May Be Kinder to Kidneys

Cilnidipine and benidipine belong to the same calcium channel blocker family as amlodipine, so they lower blood pressure in a similar way. They differ in how they act on the small vessels around the kidney filter, which is why researchers tested them for protein in the urine. Cilnidipine relaxes both vessels around the filter, which may lower pressure inside it.19PubMed. Ca2+ channel subtypes and pharmacology in the kidney Added to an ACE inhibitor or ARB, it lowered urine protein more than amlodipine in people with kidney disease.20PubMed. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease Benidipine with an ARB cut urine protein by about 29% over 6 months, versus about 8% with amlodipine.21Hypertension Research. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney disease

Results don’t all point one way. In people with type 2 diabetes on an ACE inhibitor or ARB, cilnidipine offered no more kidney protection than amlodipine.22PubMed Central. Reno protective role of amlodipine in patients with hypertensive chronic kidney disease Neither verapamil nor amlodipine meaningfully changed urine protein when added to trandolapril.23PubMed. The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study Verapamil is a different kind of calcium channel blocker, so any benefit may not be shared across the whole class. The studies measured protein rather than long-term outcomes like dialysis, so a bigger drop is encouraging but not proof of longer kidney survival. Most were done in Japan and other Asian populations, and results may not carry over to everyone.

Cilnidipine and benidipine are mainly sold in Japan and parts of Asia. In the US and Europe, adding an ACE inhibitor or ARB is the usual route, and the evidence for these drugs comes from smaller studies than the big amlodipine trials. In every comparison here, the drugs were added to an ACE inhibitor or ARB, which suggests that base drug does most of the protective work. If your urine protein is already low, there is little reason to chase a different calcium channel blocker. If it stays high, ask whether the ACE inhibitor or ARB dose can be optimized and whether other causes are being addressed, and raise switching only then.

Ankle Swelling Is Not a Kidney Warning

Swelling of the ankles and feet is common on calcium channel blockers and happens without salt retention or heart failure.24PubMed. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension The drug widens small arteries more than veins in the legs, so pressure in the tiny capillaries rises and fluid leaks into surrounding tissue. It’s a local effect in the lower legs rather than extra salt and water held by the whole body, which is why scales often show no sudden weight gain. It’s usually a nuisance side effect, not a sign of kidney damage. And because it isn’t extra body water, water pills often don’t help much.

Amlodipine swelling sits low in the ankles and worsens through the day. Kidney-related swelling may also show around the eyes or come with foamy urine. Swelling with breathlessness or rapid weight gain needs prompt attention. So does swelling in just one leg, especially with pain or warmth, which can signal a blood clot.

Swelling grows with dose, so ask about a lower one. Adding an ACE inhibitor or ARB often eases it, and raising your legs helps briefly. Swelling is a leading reason people ask to change drugs, and switching is reasonable for comfort, though it isn’t needed for kidney protection.

Kidney Disease, Dialysis, and Dose

In people with reduced kidney function, blood levels of amlodipine stayed steady over weeks at 2.5 mg and 5 mg daily.25PubMed. Efficacy and safety of amlodipine in hypertensive patients with renal dysfunction Because amlodipine is broken down mostly by the liver, not cleared through urine, it doesn’t accumulate when kidneys filter poorly, so standard doses are typically used even in advanced kidney disease. Liver problems are where a doctor is more likely to start with a lower dose, since the drug lingers longer there. Dialysis doesn’t remove much amlodipine, and doctors typically don’t give extra doses afterward.

Kidney injury from amlodipine has been reported mainly with overdose, where blood pressure drops so low that the kidneys are starved of blood.26PubMed Central. A Case Report of Acute Renal Failure due to Amlodipine Overdose and Alcohol Consumption The real danger is very low blood pressure, not normal doses. Warning signs include dizziness on standing or fainting, much less urine than usual, and feeling faint during an illness with vomiting or diarrhea. Call your doctor, who may pause blood pressure pills temporarily.

If you have a transplant, note that amlodipine can raise levels of the transplant drug tacrolimus, so levels need checking after you start it. Tell every prescriber you take amlodipine.

What to Do If You’re Worried

Stopping amlodipine suddenly lets blood pressure climb, which itself harms kidneys. Talk to your doctor before any change. If swelling or another side effect is why you want to stop, say so specifically, since a dose change or swap can be arranged with a plan for your pressure.

If you have diabetes or kidney disease, ask for an eGFR blood test and a urine protein test at least yearly. Questions worth bringing: Is my kidney filtering score stable over time? Do I have protein in my urine? Would an ACE inhibitor or ARB help me? Is my dose right if I have ankle swelling?

Bring recent home blood pressure readings, which show how well the pill works in daily life better than a single office reading. Bring a list of every medicine and supplement you take, including over-the-counter pain relievers like ibuprofen, which can strain kidneys and raise blood pressure. Ask when your last filtering score and urine protein test were done and what the results were, so you can see the trend rather than just “normal.”